Treatment of Reactive Depression
For reactive depression, initiate treatment with either a second-generation antidepressant OR a brief psychological intervention (cognitive therapy, CBT, interpersonal therapy, or psychodynamic therapy), as both show similar efficacy for acute-phase major depressive disorder, with the choice guided by adverse event profiles and patient preference 1, 2.
First-Line Treatment Options
The most recent ACP clinical guideline (2024) establishes that nonpharmacologic and pharmacologic treatments demonstrate comparable benefits in acute-phase major depressive disorder 1, 2. This applies to what was historically termed "reactive depression," now subsumed under major depressive disorder in modern diagnostic frameworks 3.
Pharmacologic Approach
- Second-generation antidepressants (SSRIs, SNRIs, and related agents) are effective first-line options
- These medications carry higher risks for discontinuation due to adverse events compared to psychological interventions 2
- More than 60% of patients experience at least one adverse effect 2
- Up to 70% do not achieve remission with initial treatment 2
Nonpharmacologic Approach
- Brief psychological interventions are equally effective and include:
- These interventions have lower discontinuation rates due to adverse events 2
Combined Treatment Strategy
Combining antidepressants with psychotherapy is more effective than either treatment alone 4. This represents the most robust approach when resources permit, particularly for moderate to severe presentations.
Second-Step Strategies for Inadequate Response
When initial treatment fails (which occurs in up to 70% of cases 2):
- Switching to a different second-generation antidepressant shows similar efficacy to other switching strategies 1
- Augmentation strategies (adding a second medication or psychological intervention) provide comparable symptomatic relief to switching 2
- The choice between switching versus augmentation should be based on tolerability of the current medication and severity of residual symptoms
Maintenance Treatment
- Continue antidepressants for 6 months after acute phase to prevent relapses 4
- Consider maintenance treatment after three lifetime episodes 4
Important Clinical Caveats
The certainty of evidence is low for most treatment comparisons 2. This means that while treatments show similar benefits, the strength of evidence supporting specific choices is limited. In this context:
- Patient preference becomes a critical decision factor
- Adverse event profiles should heavily influence selection (antidepressants have higher discontinuation rates) 2
- The historical distinction between "reactive" and "endogenous" depression is no longer clinically useful for treatment selection under current diagnostic frameworks 3
Primary care settings are appropriate for managing mild to moderate depression, with psychiatric consultation services available for complex cases 4.